Literature DB >> 3118721

Iris lymphocytic infiltration in patients with clinically quiescent uveitis.

G Stevens1, C C Chan, R P Wetzig, R B Nussenblatt, A G Palestine.   

Abstract

Iridectomy specimens from 16 patients with clinically quiet chronic uveitis were analyzed by immunoperoxidase staining and compared to control iridectomy specimens from 11 non-uveitic patients. Nine of 16 uveitis specimens and none of the control specimens demonstrated a lymphocytic infiltrate consisting of interleukin-2 receptor-negative T helper and suppressor cells (P less than .003). Class II antigens were detected in the iris stroma in all uveitis specimens and six of the controls (P less than .006). Despite a quiescent clinical state, patients with chronic uveitis have increased expression of class II antigens in uveal tissue and have significant uveal infiltration of T helper and suppressor cells. These findings in a variety of types of uveitis give additional support for the importance of delayed type hypersensitivity mechanisms in human uveitic disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3118721     DOI: 10.1016/s0002-9394(14)74109-1

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  4 in total

Review 1.  Immunopathology of uveitis.

Authors:  C C Chan; Q Li
Journal:  Br J Ophthalmol       Date:  1998-01       Impact factor: 4.638

2.  Immunopathology of ocular onchocerciasis. I. Inflammatory cells infiltrating the anterior segment.

Authors:  C C Chan; E A Ottesen; K Awadzi; R Badu; R B Nussenblatt
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

3.  Adhesion molecules in iris biopsy specimens from patients with uveitis.

Authors:  E La Heij; R W Kuijpers; S G Baarsma; A Kijlstra; M van der Weiden; C M Mooy
Journal:  Br J Ophthalmol       Date:  1998-04       Impact factor: 4.638

4.  Influence of Cytokines on Inflammatory Eye Diseases: A Citation Network Study.

Authors:  Beatriz G Gálvez; Clara Martinez-Perez; Cesar Villa-Collar; Cristina Alvarez-Peregrina; Miguel Ángel Sánchez-Tena
Journal:  J Clin Med       Date:  2022-01-27       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.